×
About 1,643 results

ALLMedicine™ Cardiovascular Risk Reduction Center

Research & Reviews  465 results

Implementing DASH-aligned Congregate Meals and Self-Measured Blood Pressure in two seni...
https://doi.org/10.1016/j.numecd.2022.05.018
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Hashemi A, Vasquez K et. al.

Jun 26th, 2022 - Cardiovascular Disease (CVD) poses significant health risks for seniors, especially among low-income and minority communities. Senior centers offer multiple services. We tested whether implementing two evidence-based interventions- DASH-aligned me...

CPAP and Cardiovascular Risk Reduction in Patients Without Excessive Sleepiness: Import...
https://doi.org/10.1164/rccm.202206-1050ED
American Journal of Respiratory and Critical Care Medicine; Pamidi S, Shah N

Jun 9th, 2022 - CPAP and Cardiovascular Risk Reduction in Patients Without Excessive Sleepiness: Importance of the Pulse Rate Response.|2022|Pamidi S,Shah N,|

Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Gui...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972581
Journal of the American College of Cardiology; Kelsey MD, Nelson AJ et. al.

May 6th, 2022 - Cardiovascular disease is a leading cause of morbidity and mortality in individuals with type 2 diabetes mellitus. These high-risk patients benefit from aggressive risk factor management, with blood pressure and low-density lipoprotein-cholesterol...

PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk r...
https://doi.org/10.1136/bmj-2021-069116
BMJ (Clinical Research Ed.); Khan SU, Yedlapati SH et. al.

May 5th, 2022 - To compare the impact of ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on cardiovascular outcomes in adults taking maximally tolerated statin therapy or who are statin intolerant. Network meta-analysis. Medline, EM...

see more →

Guidelines  6 results

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545583
Journal of the American College of Cardiology; Das SR, Everett BM et. al.

Aug 11th, 2020 - 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.|2020|Das SR,Everett BM,Birtcher KK,Brown...

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk R...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560953
Journal of the American College of Cardiology; Das SR, Everett BM et. al.

Dec 1st, 2018 - 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consen...

Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721815
Journal of the American Heart Association; Levine GN, Lange RA et. al.

Oct 1st, 2017 - Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary preventio...

Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" ...
https://doi.org/10.1016/j.numecd.2016.11.122
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Pirro M, Vetrani C et. al.

Dec 14th, 2016 - Evidence showed that LDL-cholesterol lowering is associated with a significant cardiovascular risk reduction. The initial therapeutic approach to hypercholesterolemia includes dietary modifications but the compliance to recommendations is often in...

The most important meal of the day: why children skip breakfast and what can be done ab...
https://doi.org/10.3928/00904481-20130823-10
Pediatric Annals; Jackson LW

Sep 3rd, 2013 - We all experience that morning rush to get somewhere - to work, to school, or to complete a number of important errands before we reach those final destinations. Many adults skip meals for a variety of reasons. Children and teenagers are no differ...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  61 results

Effects of Life Style Intervention Manual in Pre Hypertensive Sedentary Population
https://clinicaltrials.gov/ct2/show/NCT04841902

Apr 19th, 2022 - Adoption of healthy lifestyles by all persons is critical for the prevention of high BP and is an indispensable part of the management of those with hypertension. Weight loss of as little as 10 lbs (4.5 kg) reduces BP and/or prevents hypertension ...

Lifestyle Intervention Plus Emotion Regulation Group Intervention Impact on Women's Cardiovascular Risk Reduction
https://clinicaltrials.gov/ct2/show/NCT03167489

Apr 18th, 2022 - Group lifestyle interventions (LI) have documented efficacy in improving cardiovascular disease (CVD) risk factors, however, many fail to demonstrate outcome maintenance. Existing LIs primarily focus on behavioral regulation, neglecting to address...

SHOWME-PAD (Peripheral Artery Disease)
https://clinicaltrials.gov/ct2/show/NCT03190382

Apr 8th, 2022 - Peripheral arterial disease (PAD) is a burdensome condition that affects 10% of the population and increases to 15-20% among those ≥70 years. In PAD, the underlying pathophysiologic process, atherosclerosis, presents itself as blockages in patient...

Effect of a Hybrid Rehabilitation Program on Walking, Quality of Life & Cardiovascular Risk in People With PAD
https://clinicaltrials.gov/ct2/show/NCT03649204

Mar 14th, 2022 - Peripheral arterial disease (PAD), a disabling condition, affects 800,000 Canadians. People with PAD suffer from poor quality of life due to leg pain, which makes walking difficult. They also have a high risk of heart disease. In November of 2017,...

Cardiovascular Risk Reduction-Diet in Pregnancy - Follow up 20 Years After the "CARRDIP"-Trial
https://clinicaltrials.gov/ct2/show/NCT05030922

Mar 8th, 2022 - The "Cardiovascular Risk Reduction-Diet in Pregnancy" (CARRDIP) - is a randomised controlled trial with dietary intervention during pregnancy. The participants were enrolled in Norway 20 years ago and consisted of 269 pregnant, healthy mothers. Th...

see more →

News  122 results

ADA-EASD: More Holistic Approach Needed for Hyperglycemia Management
https://www.medscape.com/viewarticle/975212

Jun 23rd, 2022 - This transcript has been edited for clarity. In the 2022 Management of Hyperglycemia consensus statement from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), the focus has shifted. Regarding t...

A Brave New World in Type 2 Diabetes Treatment and Beyond
https://www.medscape.com/viewarticle/963270

Mar 22nd, 2022 - This transcript has been edited for clarity. Silvio Inzucchi, MD: Welcome to Medscape InDiscussion. I'm your host, Dr Silvio Inzucchi from Yale School of Medicine. Today we're talking about cardiovascular effects of type 2 diabetes medications and...

Full-press Therapy Rare in Diabetes With ASCVD
https://www.medscape.com/viewarticle/968881

Feb 19th, 2022 - A high percentage of people with type 2 diabetes also have atherosclerotic cardiovascular disease (ASCVD), but fewer than 1 in 20 get the triumvirate of evidence-based medications – drugs to lower cholesterol, blood pressure, and glucose levels – ...

Full-press therapy rare in diabetes with ASCVD
https://www.mdedge.com/cardiology/article/251951/diabetes/full-press-therapy-rare-diabetes-ascvd
Richard Mark Kirkner

Feb 18th, 2022 - A high percentage of people with type 2 diabetes also have atherosclerotic cardiovascular disease (ASCVD), but fewer than 1 in 20 get the triumvirate of evidence-based medications – drugs to lower cholesterol, blood pressure, and glucose levels –.

Top 10 Take-home Messages From the 2018 ACC/AHA Cholesterol Guidelines
https://www.medscape.com/viewarticle/958747

Dec 15th, 2021 - This transcript has been edited for clarity. Laurence Sperling, MD: Welcome to Medscape's InDiscussion series on dyslipidemia. This is episode four, "The Top 10 Take-Home Messages From the 2018 ACC/AHA Cholesterol Guidelines." Today we are fortuna...

see more →